EUVIMED · CrossrefZeitschrift
Annals of Hematology
ISSN 1432-0584 · Springer Science and Business Media LLC
Neueste Artikel
Identification of high-frequency genes in non-severe aplastic anemia and their impact on therapeutic response
Updated analysis of overall survival with imetelstat in relapsed/refractory myelofibrosis versus real-world data, and assessment of real-world treatment patterns
POD12 in mantle cell lymphoma: comparison with POD24, post-progression survival, and BTK inhibitor exposure
Clinical activity of luspatercept in patients with poor erythroid engraftment after allogeneic hematopoietic stem cell transplantation
A systematic review of safety and efficacy of pyruvate kinase activators in inherited hemolytic anemia
In-hospital mortality, hemorrhagic complications, and sociodemographic disparities in acute promyelocytic leukemia: a nationwide analysis of the United States, 2016 to 2023
Poor graft function after allogeneic hematopoietic cell transplantation: From definition to mechanism-based management
When recipient testing becomes donor testing: recognizing incidental genetic findings of potential donor origin after allogeneic hematopoietic cell transplantation
Clinical features and prognostic impact of hemophagocytic lymphohistiocytosis in angioimmunoblastic T-cell lymphoma: a single-center retrospective study
Response predictors and clonal evolution during thalidomide therapy in myelodysplastic neoplasms with increased blasts
Durable remission for more than 5 years with gilteritinib in FLT3-ITD-positive acute myeloid leukemia relapsing after a second allogeneic transplantation
Clinicopathological analysis of large B-cell lymphoma with MYC rearrangement and 11q aberrations: a retrospective case series
Clinical efficacy and safety of lysine-specific demethylase 1 inhibitors in hematologic malignancies: a systematic review of clinical trials
Factors associated with the medical feasibility of completing full-course standard-dose R-CHOP-based therapy in older patients with diffuse large B-cell lymphoma: Development of a clinical risk score
Marrow remodeling is associated with adverse co-mutational complexity in CALR-mutated primary myelofibrosis: a clinicopathologic study
Donor lymphocyte infusions as pre-emptive and therapeutic strategy for post-transplant acute lymphoblastic leukemia relapse: A retrospective single-center analysis on 16 consecutive patients
Clofarabine and intermediate-dose cytarabine after venetoclax failure in relapsed/refractory acute myeloid leukemia: a retrospective single-center experience
Consolidative allogeneic stem cell transplantation following bispecific antibody salvage in relapsed/refractory high-grade B-cell lymphoma: representative cases and literature review
Mutational landscape of gastric extranodal marginal zone lymphoma according to Helicobacter pylori status
De novo adult T-cell leukemia/lymphoma of donor cell origin after allogeneic hematopoietic stem cell transplantation from an HTLV-1 negative sibling: a case report
Post-transplant BRAF/MEK inhibitor maintenance sustains complete remission in BRAF V600E-mutant histiocytic sarcoma
Correction to: Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
Evaluating the effectiveness of the eHealth-faciLitated SMILe–integrated care model on treatment burden, quality of life and graft-versus-host disease after allogeneic stem cell transplantation: results of two European randomized controlled implementation studies
Patient-tailored azacitidine, venetoclax and gilteritinib triplet therapy appear to improve tolerability while preserving encouraging clinical outcomes in FLT3-mutated relapsed/refractory AML
Sickle cell disease in Germany – trends in epidemiology, healthcare utilization and disease burden from 2015 to 2024: a claims data analysis
Epstein-barr virus-associated hemophagocytic lymphohistiocytosis after antithymocyte globulin-conditioned allogeneic hematopoietic stem cell transplantation: a single-center case series
Primary thyroid diffuse large B-cell lymphoma: a case report and focused review of the literature
Final results of the CARO study: real-world adherence, effectiveness and patient-reported quality of life with carfilzomib-based regimens in German patients with relapsed/refractory multiple myeloma
Haploidentical hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for severe aplastic anemia patients aged 40–65: a multicenter retrospective study
Clinical outcomes of T-cell acute lymphoblastic leukemia versus T-cell lymphoblastic lymphoma after allogeneic hematopoietic stem cell transplantation
Jahrgänge
2026 · 4212025 · 5902024 · 6752023 · 4342022 · 3942021 · 3872020 · 3872019 · 3702018 · 3202017 · 3142016 · 3262015 · 3402014 · 3292013 · 2762012 · 3012011 · 2432010 · 2322009 · 2192008 · 1892007 · 1452006 · 1932005 · 1822004 · 1702003 · 1862002 · 1692001 · 1982000 · 1311999 · 1101998 · 1111997 · 1061996 · 1421995 · 2241994 · 1591993 · 1321992 · 1411991 · 1221990 · 1261989 · 1411988 · 1171987 · 140
EUVIMED